Add to ORKGPrognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin’s lymphoma autografted after a first relaps
BACKGROUND: Early autologous hemopoietic stem cell transplant is the best option for treatment of re...
Autologous stem-cell transplantation (autoSCT) is considered a standard treatment of non-frail patie...
Long-term outcome of autologous stem cell transplantation in light chain deposition diseas
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin’s lymphoma...
Background: High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the st...
Objective: To identify the prognostic factors in relapsed Hodgkin’s Lymphoma patients with regards t...
Purpose: Our aim was to capture the biology of classical Hodgkin lymphoma (cHL) at the time of relap...
Hodgkin lymphoma (HL) patients who relapse after autologous-stem-cell- transplantation (auto-SCT) ha...
Background: Novel agents are changing the treatment of relapsed or refractory Hodgkin lymphoma (HL)....
IF 11.855International audienceBackground:Novel agents are changing the treatment of relapsed or ref...
OBJECTIVE: To assess the prognostic value of various parameters including positron emission tomograp...
BACKGROUND: Patients with follicular lymphoma (FL) relapsing after an autologous transplant (autoSCT...
Patients with relapsed/progressed Hodgkin’s lymphoma (HL) following autologous hematopoietic cell tr...
Abstract: Long-term survivors of Hodgkin’s lymphoma are at increased risk for a number of late compl...
In the CORAL study, 255 chemosensitive relapses with diffuse large B-cell lymphoma (DLBCL) were cons...
BACKGROUND: Early autologous hemopoietic stem cell transplant is the best option for treatment of re...
Autologous stem-cell transplantation (autoSCT) is considered a standard treatment of non-frail patie...
Long-term outcome of autologous stem cell transplantation in light chain deposition diseas
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin’s lymphoma...
Background: High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the st...
Objective: To identify the prognostic factors in relapsed Hodgkin’s Lymphoma patients with regards t...
Purpose: Our aim was to capture the biology of classical Hodgkin lymphoma (cHL) at the time of relap...
Hodgkin lymphoma (HL) patients who relapse after autologous-stem-cell- transplantation (auto-SCT) ha...
Background: Novel agents are changing the treatment of relapsed or refractory Hodgkin lymphoma (HL)....
IF 11.855International audienceBackground:Novel agents are changing the treatment of relapsed or ref...
OBJECTIVE: To assess the prognostic value of various parameters including positron emission tomograp...
BACKGROUND: Patients with follicular lymphoma (FL) relapsing after an autologous transplant (autoSCT...
Patients with relapsed/progressed Hodgkin’s lymphoma (HL) following autologous hematopoietic cell tr...
Abstract: Long-term survivors of Hodgkin’s lymphoma are at increased risk for a number of late compl...
In the CORAL study, 255 chemosensitive relapses with diffuse large B-cell lymphoma (DLBCL) were cons...
BACKGROUND: Early autologous hemopoietic stem cell transplant is the best option for treatment of re...
Autologous stem-cell transplantation (autoSCT) is considered a standard treatment of non-frail patie...
Long-term outcome of autologous stem cell transplantation in light chain deposition diseas